133 related articles for article (PubMed ID: 38018280)
1. Nanoparticle-Mediated Delivery of Anti-PU.1 siRNA via Localized Intracisternal Administration Reduces Neuroinflammation.
Ralvenius WT; Andresen JL; Huston MM; Penney J; Bonner JM; Fenton OS; Langer R; Tsai LH
Adv Mater; 2024 Feb; 36(8):e2309225. PubMed ID: 38018280
[TBL] [Abstract][Full Text] [Related]
2. A novel molecular class that recruits HDAC/MECP2 complexes to PU.1 motifs reduces neuroinflammation.
Ralvenius WT; Mungenast AE; Woolf H; Huston MM; Gillingham TZ; Godin SK; Penney J; Cam HP; Gao F; Fernandez CG; Czako B; Lightfoot Y; Ray WJ; Beckmann A; Goate AM; Marcora E; Romero-Molina C; Ayata P; Schaefer A; Gjoneska E; Tsai LH
J Exp Med; 2023 Nov; 220(11):. PubMed ID: 37642942
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease.
Ahmed T
Eur J Neurosci; 2024 Jun; 59(11):2915-2954. PubMed ID: 38622050
[TBL] [Abstract][Full Text] [Related]
5. PU.1 regulates Alzheimer's disease-associated genes in primary human microglia.
Rustenhoven J; Smith AM; Smyth LC; Jansson D; Scotter EL; Swanson MEV; Aalderink M; Coppieters N; Narayan P; Handley R; Overall C; Park TIH; Schweder P; Heppner P; Curtis MA; Faull RLM; Dragunow M
Mol Neurodegener; 2018 Aug; 13(1):44. PubMed ID: 30124174
[TBL] [Abstract][Full Text] [Related]
6. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
7. Regulation of neuroinflammation in Alzheimer's disease via nanoparticle-loaded phytocompounds with anti-inflammatory and autophagy-inducing properties.
Nayak V; Patra S; Rout S; Jena AB; Sharma R; Pattanaik KP; Singh J; Pandey SS; Singh RP; Majhi S; Singh KR; Kerry RG
Phytomedicine; 2024 Jan; 122():155150. PubMed ID: 37944239
[TBL] [Abstract][Full Text] [Related]
8. Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor.
Hsu SH; Yu B; Wang X; Lu Y; Schmidt CR; Lee RJ; Lee LJ; Jacob ST; Ghoshal K
Nanomedicine; 2013 Nov; 9(8):1169-80. PubMed ID: 23727126
[TBL] [Abstract][Full Text] [Related]
9. Precision treatment of viral pneumonia through macrophage-targeted lipid nanoparticle delivery.
Zhao G; Xue L; Geisler HC; Xu J; Li X; Mitchell MJ; Vaughan AE
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2314747121. PubMed ID: 38315853
[TBL] [Abstract][Full Text] [Related]
10. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo.
Jyotsana N; Sharma A; Chaturvedi A; Budida R; Scherr M; Kuchenbauer F; Lindner R; Noyan F; Sühs KW; Stangel M; Grote-Koska D; Brand K; Vornlocher HP; Eder M; Thol F; Ganser A; Humphries RK; Ramsay E; Cullis P; Heuser M
Ann Hematol; 2019 Aug; 98(8):1905-1918. PubMed ID: 31104089
[TBL] [Abstract][Full Text] [Related]
12. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH
Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874
[TBL] [Abstract][Full Text] [Related]
13. The efficiency of lipid nanoparticles with an original cationic lipid as a siRNA delivery system for macrophages and dendritic cells.
Uemura Y; Naoi T; Kanai Y; Kobayashi K
Pharm Dev Technol; 2019 Mar; 24(3):263-268. PubMed ID: 29688101
[TBL] [Abstract][Full Text] [Related]
14. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
Zimmermann CM; Baldassi D; Chan K; Adams NBP; Neumann A; Porras-Gonzalez DL; Wei X; Kneidinger N; Stoleriu MG; Burgstaller G; Witzigmann D; Luciani P; Merkel OM
J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
[TBL] [Abstract][Full Text] [Related]
15. siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer.
Yamamoto Y; Lin PJ; Beraldi E; Zhang F; Kawai Y; Leong J; Katsumi H; Fazli L; Fraser R; Cullis PR; Gleave M
Clin Cancer Res; 2015 Nov; 21(21):4845-55. PubMed ID: 26106075
[TBL] [Abstract][Full Text] [Related]
16. Spermidine reduces neuroinflammation and soluble amyloid beta in an Alzheimer's disease mouse model.
Freitag K; Sterczyk N; Wendlinger S; Obermayer B; Schulz J; Farztdinov V; Mülleder M; Ralser M; Houtman J; Fleck L; Braeuning C; Sansevrino R; Hoffmann C; Milovanovic D; Sigrist SJ; Conrad T; Beule D; Heppner FL; Jendrach M
J Neuroinflammation; 2022 Jul; 19(1):172. PubMed ID: 35780157
[TBL] [Abstract][Full Text] [Related]
17. Engineered ionizable lipid nanoparticles mediated efficient siRNA delivery to macrophages for anti-inflammatory treatment of acute liver injury.
Zhang H; Ding F; Zhu Z; Sun Q; Yang C
Int J Pharm; 2023 Jan; 631():122489. PubMed ID: 36521639
[TBL] [Abstract][Full Text] [Related]
18. Development of amino acid-modified biodegradable lipid nanoparticles for siRNA delivery.
Patel P; Fetse J; Lin CY; Guo Y; Hasan MR; Nakhjiri M; Zhao Z; Jain A; Cheng K
Acta Biomater; 2022 Dec; 154():374-384. PubMed ID: 36191773
[TBL] [Abstract][Full Text] [Related]
19. Pathological Changes in Alzheimer's Disease Analyzed Using Induced Pluripotent Stem Cell-Derived Human Microglia-Like Cells.
Xu M; Zhang L; Liu G; Jiang N; Zhou W; Zhang Y
J Alzheimers Dis; 2019; 67(1):357-368. PubMed ID: 30562902
[TBL] [Abstract][Full Text] [Related]
20. In vivo Evaluation and Alzheimer's Disease Treatment Outcome of siRNA Loaded Dual Targeting Drug Delivery System.
Zhang C; Gu Z; Shen L; Liu X; Lin H
Curr Pharm Biotechnol; 2019; 20(1):56-62. PubMed ID: 30727887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
